FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Johnson Matthey Remifentanil HCl active pharmaceutical Recall

Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing o…

Johnson Matthey Inc. · West Deptford, NJ

Risk level
Class III
Reported by FDA
Apr 24, 2019
Recall ID
D-1252-2019
Check your lot numberHow we source this data

Summary

Johnson Matthey recalled Remifentanil HCl active pharmaceutical starting Apr 2, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1252-2019 on Apr 24, 2019. Reason: Failed Impurities/Degradation Specifications: Unknown impurity above specification limits. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Unknown impurity above specification limits.

Product description

Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging, 416.95 g glass container, Rx ONLY, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742.

Lot numbers, UPCs & expiration codes

Lot #: B1319-170101

Where it was sold

Product was distributed to one manufacturer in Morgantown, WV who may have manufactured the product into finished product and further distribute to the retail level Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1252-2019
Classification
Class III
Status
Terminated
Recall initiated
Apr 2, 2019
FDA report date
Apr 24, 2019
Quantity
416.95 g glass container
Recall type
Voluntary: Firm initiated
Recalling firm
Johnson Matthey Inc.

Original FDA data

Every field from FDA enforcement report D-1252-2019, exactly as published.

Show all FDA fields
City
West Deptford
State
NJ
Status
Terminated
Country
United States
Event ID
82618
Address
2003 Nolte Dr
Code information
Lot #: B1319-170101
Postal code
08066-1727
Report date
Apr 24, 2019
Product type
Drugs
Recall number
D-1252-2019
Classification
Class III
Recalling firm
Johnson Matthey Inc.
Product quantity
416.95 g glass container
Termination date
Jan 10, 2020
Reason for recall
Failed Impurities/Degradation Specifications: Unknown impurity above specification limits.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging, 416.95 g glass container, Rx ONLY, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742.
Distribution pattern
Product was distributed to one manufacturer in Morgantown, WV who may have manufactured the product into finished product and further distribute to the retail level Nationwide in the USA.
Recall initiation date
Apr 2, 2019
Initial firm notification
E-Mail
Center classification date
Apr 30, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1252-2019, published Apr 24, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls